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Abstract
Over the past decades, health-related quality of life (HRQL) has become a major 
topic of research in the context of chronic conditions, including chronic obstructive 
pulmonary disease (COPD). HRQL assessment became a part of the mandatory 
criteria for judging the effectiveness of a therapeutic care plan. COPD still imposes 
an enormous burden on patients and health care systems. Daily symptoms, poor 
pulmonary function, and medication use can affect the social and physical life 
components of patients. Indeed, HRQL predictors in COPD patients were con-
troversial in the literature. To this end, we conducted a review of the literature to 
describe COPD-related factors that influence the HRQL of patients. This study 
included research articles published in English from 2010 to 2020. This review of 
sparse and well-designed literature gave a current state-of-the-art that could be 
useful for clinicians, and in establishing advanced COPD management plans.
Keywords: COPD, quality of life, dyspnea, exacerbation, comorbidity,  
disease management
1. Introduction
Chronic obstructive pulmonary disease (COPD) is a lung disease that is char-
acterized by a persistent blockage of the flow of inhaled gases. It tends to be an 
under-diagnosed condition, which engages the life prognosis [1]. In fact, COPD is 
a growing global health problem that caused 4.07% of total disability adjusted life 
years in adults aged 50 to 69 years [2]. It is currently the fourth leading cause of 
death worldwide [3]. More than 3 million people worldwide died of COPD in 2012, 
which was equal to 6% of all deaths globally [4].
Although this condition is not curable, pharmacological and non-pharmacological 
treatments can slow the progression of the disease [1]. Symptoms, such as dyspnea, 
cough, and sputum, can lead to exercise intolerance and restriction in daily life activi-
ties of patients with COPD [5, 6]. Consequently, they progressively impair the health 
related quality of life (HRQL) [6]. According to Roche and Similowski, impaired 
HRQL is a major issue in chronic disease management. Its measurement is currently 
part of the mandatory criteria for judging the effectiveness of a treatment or a plan of 
chronic condition management [7].
Indeed, HRQL was defined by the World Health Organization since 1984 as 
the individual’s perception of his place in life, in the context of the culture and 
value system in which he or she lives, in relation to his objectives, expectations, 
standards and concerns. It is a very broad concept, influenced in a complex way 
by the physical health of the person, his or her psychological state, his or her level 
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of independence, his or her social relations, as well as his or her relationship to the 
essential elements of his or her environment [8]. This perception may vary with 
age, health status, maturity, and over time [9, 10]. Thus, it is important to periodi-
cally assess the HRQL of patients.
In fact, HRQL assessment is an important indicator in healthcare since it pro-
vides an overview of the impact of the disease on the patient’s life. It is substantial 
for optimizing patient comfort and improving care [7]. In research, HRQL assess-
ment is interesting to justify various forms of treatment. It helps in improving 
therapies and providing significant data to judge the Cost/Effectiveness ratio of 
healthcare therapies [11].
One of the main objectives of COPD treatment was to improve the general 
health condition of patients. As a result, HRQL has become a major topic of 
research in COPD patients [12, 13]. Several studies assessed the factors determining 
the HRQL in patients with COPD using various methods and instruments. Indeed, 
predictors of HRQL were controversial in the literature. Furthermore, it is crucial 
to identify clinical factors related to COPD that affect the HRQL of patients. This 
could be useful and time-saving for health care providers in developing advanced 
and evidence-based COPD management programs.
In this chapter, we aimed to describe the findings of studies that analyzed clini-
cal factors determining the HRQL of COPD patients published in the past decade.
2. Methods
2.1 Study design
This was a literature review of analytical studies that assessed the clinical factors 
determining the HRQL in patients with COPD.
2.2 Sources of information and data search
The data search was carried out using three electronic databases, namely, 
MEDLINE, ScienceDirect, and Mendeley. Data collection was conducted from 
December 2020 to January 2021. Studies identified in the references of the selected 
articles, and that met the inclusion criteria were included in this review.
The terms used for the search were ‘quality of life’, ‘Pulmonary Disease, Chronic 
Obstructive’, ‘epidemiologic factors’, ‘risk factors’, ‘influencing factors’, ‘outcomes 
and process assessment’ in different combinations.
2.3 Inclusion criteria
Studies were primarily assessed basing on their titles and abstracts. After exclu-
sion of duplicates, studies were included in this review according to the following 
inclusion criteria: English language articles published in scientific journals, the 
study included generic or specific instruments or both of them to collect informa-
tion on predictors of HRQL among COPD patients, the study included only COPD 
patients, the work included quantitative information on clinical predictors of HRQL 
and articles published from 2010 to 2020.
2.4 Data extraction
For each study included in this literature review, the following variables were 
recorded: author and country, study design, study period, sample size, tools  
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for HRQL assessment, and findings of the study regarding clinical factors 
influencing HRQL.
3. Results
Basing on the titles and abstracts, forty-two articles seemed to meet the objec-
tives of this review. Twenty-six articles were excluded for one of the following 
reasons: articles not written in English language, articles published before 2010 
(n = 24), samples were not exclusively COPD patients, articles aimed to assess 
HRQL without identifying predictive factors. Consequently, the final sample was 
reduced to sixteen studies.
Table 1 shows the characteristics of the included studies. The studies were con-
ducted in different regions in the world, namely European countries, South Korea, 
China, Egypt, Tunisia, and United States. Most of the studies used a multicenter, 
cross-sectional analytical design, with studies’ periods ranged from 3 months to  
6 years. Five studies used a multicenter, prospective analytical design, with 
6-month to 5-year period [14–18]. The minimal sample size used in the studies 
was n = 42, and the maximum one was 5619. The mean age of studied populations 
ranged from 59 ± 10.1 to 72.2 ± 8.11. Patients with all COPD severity stages (GOLD I 
to IV) and with co-morbidities were included in the studies.
Various tools of HRQL assessment were used in the literature (Table 1). The St 
George’s Respiratory Questionnaire (SGRQ ), which is a COPD-specific tool, was 
largely used (10 studies). Two studies used the COPD Assessment Test [19, 20].
Regarding generic instruments, the Medical Outcome Study 36-Item Short-
Form Health Survey (SF-36) and the EuroQol-5 Dimension (EQ-5D) were used 
in 6 studies. Also the Medical Outcome Study 12-Item Short-Form Health Survey 
(SF-12) was used in one study as a second tool. The severity of dyspnea was mainly 
assessed by the “Medical Research Council (MRC) dyspnea scale”.
All of the studies reported a significant HRQL impairment in patients with 
COPD. The prospective studies recorded the changes of HRQL status over time at 
6 months to 5 years’ follow-up.
Twelve papers identified more than one clinical factor affecting the HRQL in 
COPD subjects, and five articles identified only one factor [18, 19, 21–23]. COPD 
symptoms [14–16, 18, 21, 23–26], COPD severity [5, 6, 12, 24, 27], and co-morbid-
ities [5, 12, 16, 20, 24, 26, 27] were commonly identified as predictors of HRQL in 
COPD subjects.
4. Discussion
The current review reported sixteen studies with two different designs: cross 
sectional and prospective. The cross sectional study design is limited in its ability 
to draw valid conclusions as to the association between COPD-related factors and 
HRQL. Also, cross-sectional studies can present a memorization bias. Nevertheless, 
the sample size used in most of the documented studies was large enough to assess 
HRQL with adequate precision. In regards with prospective studies (n = 5), they 
eliminate the memorization bias as there is no need for information recall. Follow-up 
can provide more information concerning the changes that patients experience and 
their possible impact on HRQL. For instance, Monteagudo and colleagues observed 
a clinically important changes in HRQL in nearly two thirds of the study population 
(36.7% improving and 29.2% worsening HRQL). However, the loss to follow-up is 






























1817 5 months Cross-sectional 
epidemiological, non-
randomized study.
St George’s Respiratory 
Questionnaire, Short Form 12.




40 1 year Cross-sectional study St George’s Respiratory 
Questionnaire.
Severity of COPD, Smoking index, forced expiratory volume in 1 second (FEV1), 
FEV1/FVC ratio (FVC: Forced vital capacity), Peak expiratory flow rate (PEFR), 
Forced expiratory flow at 25%- 75% of maximal lung volume (FEF25–75%).
Monteagudo 
et al. (2013), 
Spain
791 1 year Multi center, 
prospective study
St George’s Respiratory 
Questionnaire.
Factors associated with HRQL improvement: Poly-medication, pulmonology visits, 
and a balanced diet; ending respiratory rehabilitation, quitting smoking habit, 
infrequent exacerbation.
Factors associated with HRQL worsening: Symptoms (dyspnea, expectoration), 
hospital admissions
Negi et el 
(2014), India
126 6 months Cross-sectional study St George’s Respiratory 
Questionnaire.





491 1 year Prospective cohort 
study
St George’s Respiratory 
Questionnaire.




373 11 months Multicenter, cross-
sectional study
EuroQol-5 dimension, COPD 
Assessment Test.











178 — Cross-sectional 
multicenter study
St George’s Respiratory 
Questionnaire.


















































EuroQol-5 dimension Severity of COPD, co-morbidities (Depression, osteoporosis, diabetes, 
cardiovascular disease)
Lee et al. 
(2017), 
South Korea
1,264 4 years Multi center, 
prospective study
St George’s Respiratory 
Questionnaire.




335 3 months Cross-sectional study Medical Outcome Study 36-Item 
Short-Form Health Survey 
(MOS SF-36)
COPD severity (Moderate to very severe), 2 or more co-morbidities, MRC dyspnea 





735 2 years Cross-sectional study 5 level EuroQol-5 dimension 
(EQ-5D 5 L)
Dyspnea, depression, anxiety, 12-month exacerbations.
Amini et al. 
(2020), Iran






543 5 years Prospective cohort 
study
St George’s Respiratory 
Questionnaire.
Inhaled medication, smoking habit, FEV1, 6MWT distance, body mass index, 




42 6 months Longitudinal study Medical Outcome Study 36-Item 
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Regarding to the populations’ characteristics, most of the studies addressed 
middle-age adults and/or older adults. Besides, most of the patients were between 
moderate and very severe COPD severity stages. They presented different comorbidi-
ties, such as diabetes, osteoporosis, depression, anxiety, and cardiovascular diseases.
HRQL is a multidimensional, subjective, and dynamic concept, which make it 
difficult to assess. Nevertheless, there are reliable and valid HRQL measurement 
tools in the literature. Indeed, Mercier and Schraub distinguished two methods to 
assess HRQL [29]. The first one is via psychological interview that allows a com-
prehensive evaluation of HRQL and has therapeutic value. The second method is 
via psychometric tools that consist of scales or questionnaires. It performs a restric-
tive evaluation of HRQL and allows standardized measurement. This method is 
generally easy to use. For that, we included the studies that used this type of HRQL 
evaluation in this review.
In the literature, the specific questionnaire mostly used to assess the HRQL was 
the St George’s Respiratory Questionnaire. The generic questionnaires SF-36 and 
the EQ-5D were also widely used in the literature. These instruments reported that 
COPD altered the HRQL of patients even in a mild stage [5, 6, 14, 15, 21, 23–25].
HRQL is the result of the interaction of multiple physical, psychological and 
social components. Consequently, several factors can affect it, especially in COPD 
subjects.
This review demonstrated that multiple COPD-related factors had a significant 
negative influence on the HRQL of patients with COPD.
4.1 COPD-related factors
COPD-related factors include pulmonary function, physical activity, chronic 
cough, chronic wheeze, dyspnea, exacerbations, and hospitalizations. The first 
concept related to a chronic disease is the severity stage. Therefore, the impact of 
COPD severity on HRQL was often analyzed. Five studies demonstrated that HRQL 
was deteriorated across severity stages of COPD [5, 6, 12, 24, 27]. Indeed, the more 
the disease worsens the more the HRQL deteriorates. Thus, it is important to note 
that HRQL should be considered as a substantial health status indicator in this 
population.
Symptoms, including chronic cough/sputum, wheeze, and dyspnea, were com-
monly identified as predictors of HRQL (9 studies). Eight of nine studies showed 
that an advanced dyspnea grade was associated with a worsening of HRQL scores 
[14–16, 21, 23–26]. Frequent cough [21, 22] and expectoration [14] also deteriorated 
the HRQL scores.
The negative impact of exacerbations was reported in the literature. Authors 
declared that the degree of HRQL impairment depended on the frequency of exacer-
bations [5, 14, 15]. Indeed, Liang and colleagues revealed that COPD patients who had 
3 exacerbations or more in the past 1 year had significantly an impaired HRQL [15].
One the main objectives of COPD treatment was to improve the patient’s health 
status. Indeed, Monteagudo and colleagues revealed that patients taking multiple 
medications and ending respiratory rehabilitation had improved HRQL at 1-year 
follow-up [14]. Recently, Esteban and colleagues showed that using 2 out of long-
acting beta agonists, long-acting muscarinic antagonists, and inhaled corticoste-
roid, or 3 of them was significantly associated with HRQL scores [17]. Amini and 
colleagues demonstrated that appropriate inhaler technique was associated with 
better HRQL in patients with COPD [19]. This data suggested that optimizing 
inhaler technique should be considered in COPD management programs.
Pulmonary function was significantly associated with HRQL [6, 17, 24]. 
It was shown that residual volume, diffusing capacity of the lung for carbon 
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monoxide, and low forced expiratory volume in 1 second (FEV1) predicted 
HRQL of COPD patients.
In brief, dyspnea had significantly and independently the highest impact on 
HRQL in comparison with other COPD- related factors and co-morbidities  
[12, 14–16, 24, 26]. Several research studies demonstrated that dyspnea was the 
best predictor of HRQL in COPD patients, especially MRC dyspnea grade 4 and 
5 [15, 16, 26]. Indeed, Monteagudo and colleagues revealed that the onset of new 
symptoms negatively influenced HRQL more than their persistence [14].
4.2 Co-morbidities
Patients with COPD often have at least one associated co-morbidity. 
Co-morbidities were significantly associated with HRQL impairment. Studies 
showed that the degree of impairment depended on the number of co-morbidities 
[5, 12, 16]. Indeed, COPD patients who had 2 to 3 or more co-morbidities had sig-
nificantly lower HRQL score. Anxiety, depression and other chronic diseases, such 
as diabetes, hypertension, osteoporosis, and cardiovascular disease, were associ-
ated with HRQL impairment [20, 24, 26, 27]. In fact, several studies showed that 
depression was commonly associated with HRQL worsening [20, 24, 26, 27]. Brien 
and colleagues reported that depression was associated with higher HRQL [26]. 
Besides, Kwon and Kim showed that osteoporosis and depression had the highest 
impact on HRQL in comparison with cardiovascular disease, diabetes, cancer and 
hypertension [27]. However, Sundh and colleagues revealed that chronic bronchitis 
phenotype in COPD patients indicated a higher risk of low HRQL in comparison 
with musculoskeletal symptoms, osteoporosis and depression [20].
Coping strategies can enhance the HRQL of COPD patients, but this might fail 
in case of co-morbid conditions [30]. Therefore, COPD management interventions 
should address co-morbid conditions along with COPD-related factors. Patient-
tailored care could be an appropriate strategy for optimal management of the 
disease and its associated factors.
5. Conclusions
To conclude, COPD is a burdensome disease that progressively deteriorates the 
HRQL of patients. This literature review reported that disease severity, frequent 
symptoms and exacerbations, poor lung function, inappropriate medication use 
and co-morbidities were significantly associated with HRQL impairment. Dyspnea 
had the highest impact on HRQL in comparison with other COPD-related factors. 
Besides, depression was commonly associated with a higher impairment of HRQL. 
These factors should no longer be a matter of controversy. Disease management 
interventions should be delivered as early as possible in order to prevent the onset of 
new co-morbidities and to optimize the disease control.
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